We are live on ! Find out more
BFRI icon

Biofrontera

12 hedge funds and large institutions have $1.18M invested in Biofrontera in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

6.66% less ownership

Funds ownership: 23.35% → 16.69% (-6.7%)

14% less funds holding

Funds holding: 14 → 12 (-2)

40% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 5

40% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 5

87% less capital inflows, than outflows

Capital inflows: $50.8K | Capital outflows: $395K

Holders
12
Holders Change
-2
Holders Change %
-14.29%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
5
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

BFRI Hedge Fund Activity: Q1 2025 in Review

12 of the 7,489 institutional investors tracked by Wall St. Rank reported a position in Biofrontera (BFRI) for Q1 2025, worth a combined $1.18M — down 40% from $1.97M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of BFRI and 3 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 3 added.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $29K. The largest seller was Rosalind Advisors, cutting an estimated $172K.

  • 12 institutional investors held Biofrontera (BFRI) as of Q1 2025, down from 14 in Q4 2024.
  • Funds reported $1.18M of Biofrontera stock for Q1 2025, down 40% quarter-over-quarter.
  • 3 funds opened new Biofrontera positions in Q1 2025 and 5 closed out, a net change of -2 holders.
  • The largest Biofrontera buyer in Q1 2025 was Citadel Advisors, an estimated $29K added.
  • The largest Biofrontera seller in Q1 2025 was Rosalind Advisors, an estimated $172K sold.

Based on aggregated 13F filings for Q1 2025.